Home

JBM Research

JBM Health economics

JBM Communications

How we work

About JBM

What's new?

JBM Publications

 


Email enquiry

 

 

 

 

 

 

 

 

 
 

 JBM Publications

  1. de Lusignan S, Nitsch D, Belsey J et al. Disparities in testing for renal function in UK primary care: cross-sectional study. Fam Pract 2011 Jun 30. PubMed abstract. 

  2. Belsey JD. Choice of angiotensin receptor blocker in moderate hypertension. A UK-based cost-benefit comparison of olmesartan- and candesartan-based regimens. J Med Econ 2011 Jun 28. PubMed abstract. 

  3. Gallacher SJ, Dixon T. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate and denosumab) on bone quality: a systematic review. Calcif Tissue Int 2010. Epub ahead of print.

  4. Stewart A, Aubrey P, Belsey J. Addressing the health technology assessment of biosimilar pharmaceuticals. Curr Med Res Opin 2010;26:2119-2126. PubMed abstract. 

  5. Belsey JD, Geraint M, Dixon TA. Systematic review and meta-analysis: polyethylene glycol in adults with non-organic constipation. Int J Clin Pract 2010;64:944-955. PubMed abstract.

  6.  de Lusignan S, Khunti K, Belsey J, et al. Organisation and delivery of care: A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diab Med 2010; 27:203-209. PubMed abstract. 

  7. Belsey J, Greenfield S, Candy D et al. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 2010;31:939-949. PubMed abstract.

  8. Belsey J. Principles of pharmaceutical marketing. In: Eds Edwards LD et al. Principles and practice of pharmaceutical medicine 3nd ed. Wiley London 2010.

  9. Belsey JD, Pittard JB, Rao S et al. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care. Int J Clin Pract 2009;63:439-448. PubMed abstract.

  10. Candy D, Belsey J. Macrogol (polyethylene glycol) based laxatives in children with functional constipation and faecal impaction: A systematic review. Arch Dis Childhood 2009;94:156-160. PubMed abstract.

  11. Belsey J, Epstein O, Heresbach, D. Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther 2008;29:15-28. PubMed abstract.

  12. Belsey J. Acute phosphate nephropathy--comment on Sica et al. Am J Gastroenterol 2008;103:800. PubMed abstract.

  13. Belsey J. Trend in left handed presidents may be due to chance. BMJ 2008;337:a915. PubMed abstract.

  14. Belsey JD. Switch strategies in the management of hypertension: A cost minimisation analysis of angiotensin receptor blocker based regimen. Curr Med Res Opin 2008;24:581-589. PubMed abstract.

  15. Belsey J, de Lusignan S, van Vlymen J et al. Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy. Curr Med Res Opin 2008;24:2703-2709. PubMed abstract.

  16. Belsey J, de Lusignan S, Chan T et al. Abnormal lipids in high-risk patients achieving cholesterol targets: a cross-sectional study of routinely collected UK general practice data. Curr Med Res Opin 2008;24:2551-2560. PubMed abstract.

  17. Belsey J, Krishnarajah G. Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis. Diabetes Obes Metab 2008;10 Suppl 1:1-7. PubMed abstract.

  18. Pearse RM, Belsey JD, Cole JN et al. Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Crit Care Med 2008;36:1323-1329. PubMed abstract.

  19. Amiel SA, Dixon T, Mann R et al. Hypoglycaemia in type 2 diabetes. Diabetic Med 2008;25:245-254. PubMed abstract.

  20. Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007;25:373-384. PubMed abstract.

  21. Gallacher SJ, Gallagher AP, McQuillian C et al. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int 2007;18:185-192. PubMed abstract.

  22. Belsey J. Principles of pharmaceutical marketing. In: Eds Edwards LD et al. Principles and practice of pharmaceutical medicine 2nd ed. Wiley London 2007.

  23. de Lusignan S, Hague N, Belsey J et al. The 'rule of halves' still applies to the management of cholesterol in cardiovascular disease: 2002-2005. Brit J Cardiol 2006;13:145-153.

  24. Belittlement and harassment of medical students: seems to achieve focus. BMJ 2006;333:920. PubMed abstract.

  25. Beringer T, Heyburn G, Finch M et al. Prevalence of vitamin D inadequacy in Belfast following fragility fracture. Curr Med Res Opin 2006;22:101-105. PubMed abstract.

  26. Bayly JR, Hollands RD, Riordan-Jones SE et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin 2006;22:131-137. PubMed abstract.

  27. Ryan P, Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr Med Res Opin 2006;22:211-216. PubMed abstract.

  28. Dixon T, Mitchell P, Beringer T et al. An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin 2006;22:405-415. PubMed abstract.

  29. de Lusignan S, Belsey J, Hague N et al. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study. J Public Health (Oxf) 2006;28:361-369. PubMed abstract.

  30. Bellavance A, Belsey J. Triptan preference in acute migraine management: A retrospective review of patient records from a Canadian clinic population. Headache Care 2006;3:39-43.

  31. Gallacher SJ, McQuillian C, Harkness M et al. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin 2005;21:1355-1361. PubMed abstract.

  32. Moniz C, Dixon T, Dew T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 2005;21:1891-1894. PubMed abstract.

  33. De Lusignan S, Belsey J, Hague N et al. End-digit preference in blood pressure recordings of patients with ischaemic heart disease in primary care. J Hum Hypertens 2004;18:261-265. PubMed abstract.

  34. Belsey JD. Cost effectiveness of oral triptan therapy: A trans-national comparison based on a meta-analysis of randomised controlled trials. Curr Med Res Opin 2004;20:659-669. PubMed abstract.

  35. Belsey JD. Non-steroidal anti-inflammatory induced upper gastrointestinal event rates in patients awaiting joint replacement in the United Kingdom. An epidemiologically-based burden of disease model. Curr Med Res Opin 2003;19:306-312. PubMed abstract.

  36. Belsey J, Adelman JU. Meta-analysis methodology: The battle continues. Headache 2003;43:1119-1121. PubMed abstract.

  37. Belsey J, Adelman JU. Updated meta-analysis of oral triptan therapy for migraine: Number needed to treat (NNT) and relative cost to achieve 2-hour pain-free status. Headache 2003;43:565 (Abst S114).

  38. Adelman JU, Belsey J. Meta-analysis of oral triptan therapy for migraine: Number needed to treat and relative cost to achieve relief within 2 hours. J Managed Care Pharm 2003;9:45-52. PubMed abstract.

  39. Belsey J. Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care. J Med Econ 2002;5:39-50.

  40. Belsey JD. The clinical and financial impact of oral triptans – an updated meta-analysis. J Med Econ 2002;5:79-89.

  41. Belsey J. Effect of varying pooling methods and analytical techniques on the qualitative results of triptan meta-analyses. Headache 2002;42:408.

  42. Belsey J. Me-graine or my-graine: An etymological headache. Headache 2002;42:445 (Abst S83).

  43. Belsey J. Clinical efficacy and cost-effectiveness of oral triptans: An updated meta-analysis incorporating data for almotriptan. Cephalalgia 2001;21:407 (Abst P2-K5)

  44. Belsey J. Reconciling effectiveness and tolerability in oral triptan therapy: A quantitative approach to decision making in migraine management. J Clin Res 2001;4:105-125.

  45. Belsey JD. The clinical and financial impact of oral triptans in the management of migraine in the UK: A systematic review. J Med Econ 2000;3:35-47.

  46. Phillips C, Belsey J, Shindler J. Flora pro.activ: A clinical and financial impact analysis. J Med Econ 2000;3:61-76.

  47. Belsey J. The clinical and financial impact of oral triptans in the management of migraine in the UK: A systematic review. Cephalalgia 2000;20:412 (Abst 365).

  48.  Belsey JD. Clinical outcomes in osteoporosis: The fracture intervention trial in context. Medical Dialogue 1997;480.